Global Evaluation of the Interstitial Lung Disease (ILD) Multi-Disciplinary Team (MDT)

Principal Investigators:

  • Luca Richeldi, Southampton Respiratory Biomedical Research Unit, University of Southampton, Southampton, UK
  • Kevin R. Flaherty, Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA
  • Fernando J. Martinez, Department of Medicine, Weill Cornell Medical College, New York, USA
  • Simon Walsh, Department of Radiology, King’s College London, King’s Health Partners, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK
  • Jeffery L. Myers, Medical School, Pathology, University of Michigan, Ann Arbor, MI, USA

Status: Planned study, seeking funding



Short Description:

The REG ILD Working Group intend to identify features of ILD MDTs associated with more accurate diagnosis of IPF with a view to improving diagnostic accuracy and patient stratification to optimise treatment outcomes worldwide.

To achieve this ultimate aim, two discrete, sequential research phases are proposed:

  • Phase I: A global, standardised, systematic evaluation of the diagnostic process employed by a range of dedicated and non-dedicated ILD centres worldwide.
  • Phase II: A global MDT ILD case review and diagnosis study to:
    1. Phase IIa: Assess the diagnostic agreement across ILD MDTs
    2. Phase IIb: Assess the diagnostic accuracy of ILD MDTs.

Documents and Publications




Final Publications

Additional Material